ascendis pharma glp-1 Novo Nordisk signs deal for monthly agonist ascendis pharma glp-1 receptor agonist

We build patient-specific calendars that map every recommended treatment to its appropriate interval, layer treatments by season (energy-based work concentrated in late autumn and winter when sun exposure is lower, injectables continuous across the year), and rebalance the plan at each annual review

IntechOpen 2024

Despite its critical importance, supplementing with standard oral glutathione has historically been highly ineffective

Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study

The Critical Importance of Purity in Research Now, this is where it gets interesting, and it's a point we cannot overstate